Skip to Main Content
Back to News

$JNJ stock is up 3% today. Here's what we see in our data.

None

$JNJ stock has now risen 3% today, according to our price data from Polygon. There has been approximately $805,814,824 of trading volume.

Here is what we see in our data on $JNJ:

$JNJ Insider Trading Activity

$JNJ insiders have traded $JNJ stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $JNJ stock by insiders over the last 6 months:

  • JOSEPH J WOLK (Exec VP, CFO) sold 13,015 shares for an estimated $2,002,878
  • ROBERT J DECKER (VP Corporate Controller) sold 6,999 shares for an estimated $1,160,994
  • MARK A WEINBERGER purchased 1,000 shares for an estimated $147,220
  • TIMOTHY SCHMID (EVP, WW Chair, MedTech) sold 403 shares for an estimated $62,928

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$JNJ Hedge Fund Activity

We have seen 1,427 institutional investors add shares of $JNJ stock to their portfolio, and 2,070 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$JNJ Government Contracts

We have seen $44,417,325 of award payments to $JNJ over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$JNJ Congressional Stock Trading

Members of Congress have traded $JNJ stock 18 times in the past 6 months. Of those trades, 15 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $JNJ stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$JNJ Analyst Ratings

Wall Street analysts have issued reports on $JNJ in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Citigroup issued a "Buy" rating on 01/22/2025
  • Cantor Fitzgerald issued a "Overweight" rating on 10/14/2024
  • Cowen & Co. issued a "Buy" rating on 10/14/2024
  • RBC Capital issued a "Buy" rating on 10/10/2024

To track analyst ratings and price targets for $JNJ, check out Quiver Quantitative's $JNJ forecast page.

$JNJ Price Targets

Multiple analysts have issued price targets for $JNJ recently. We have seen 9 analysts offer price targets for $JNJ in the last 6 months, with a median target of $175.0.

Here are some recent targets:

  • Vamil Divan from Guggenheim set a target price of $166.0 on 02/03/2025
  • Chris Shibutani from Goldman Sachs set a target price of $159.0 on 10/16/2024
  • Terence Flynn from Morgan Stanley set a target price of $175.0 on 10/16/2024
  • Shagun Singh from RBC Capital set a target price of $181.0 on 10/16/2024
  • Joanne Wuensch from Citigroup set a target price of $185.0 on 10/16/2024
  • Larry Biegelsen from Wells Fargo set a target price of $166.0 on 10/15/2024
  • Rick Wise from Stifel Nicolaus set a target price of $170.0 on 10/15/2024

You can track data on $JNJ on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles